Tag: HIV

Cross-Border ‘Drug Tourism’ May Be Fueling HIV Spike in Tijuana, UCSD Reports

SAN DIEGO—A so-called “drug tourism” may be fueling a new HIV outbreak in Tijuana, unabated by the COVID-19 closure of the international border, the University of California–San Diego School of Medicine researchers announced on Feb. 11 at the Conference on Retroviruses and Opportunistic Infection. Specifically, the researchers found that the HIV incidence rate among people who…


Luc Montagnier, Virologist Who Discovered HIV and Critic of COVID-19 Vaccine Mandates, Dies at 89

Luc Montagnier, a Nobel Prize-winning virologist who discovered HIV, and a critic of COVID-19 vaccine mandates, has died at the age of 89. The professor died at the American Hospital of Paris, in Neuilly-sur-Seine, France, “surrounded by his children,” reported French outlet FranceSoir on Feb. 9. The death was later confirmed by the area’s city hall. French President…


Facts Matter (Feb. 7): CDC Signals Changes to COVID-19 Vaccine Schedule, in Part to Address Heart Inflammation

The CDC recently released a statement, in which they signaled that a change is coming to their COVID vaccine schedule in order to mitigate the number of people who are experiencing heart inflammation after getting the COVID vaccine. Meanwhile, scientists who are working with Oxford University claim to have just discovered a new, highly transmissible…


Facts Matter (Jan. 7): CDC Signals Changes to COVID-19 Vaccine Schedule, in Part to Address Heart Inflammation

The CDC recently released a statement, in which they signaled that a change is coming to their COVID vaccine schedule in order to mitigate the number of people who are experiencing heart inflammation after getting the COVID vaccine. Meanwhile, scientists who are working with Oxford University claim to have just discovered a new, highly transmissible…


Highly Infectious, More Damaging HIV Variant Found in the Netherlands

A human immunodeficiency virus (HIV) variant has been discovered in the Netherlands by researchers at Oxford University, who say the variant is highly infectious and more damaging than other HIV variants and can put individuals at risk of developing AIDS “much more rapidly.” HIV is a virus that attacks the body’s immune system, which can lead…


GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead

Britain’s GlaxoSmithKline will receive $1.25 billion from Gilead Sciences as part of a settlement between its HIV medicines unit and the U.S.-based drugmaker, ending a long-drawn patent dispute. The settlement, announced by GSK on Tuesday, relates to Gilead’s antiretroviral drug Biktarvy, a medicine used to check the AIDS-causing virus, which GSK said in 2018 infringed…


COVID-19-Infected HIV Patient Developed 21 Mutations: Study

A South African woman suffering from “poorly controlled” HIV who also had COVID-19 for nine months saw the CCP virus develop at least 21 mutations while in her body, a recent preprint study found. The woman, 22, was able to overcome the CCP (Chinese Communist Party) virus which causes COVID-19, within six to nine weeks after…


FDA Approves First Injectable Medication to Lower HIV Risk

The U.S. Food and Drug Administration on Monday approved the first injectable medication to lower the risk of contracting HIV, or the human immunodeficiency virus. HIV attacks the body’s immune system and causes AIDS (acquired immunodeficiency syndrome) if not treated. The FDA-approved medication is an injectable form of GlaxoSmithKline Plc’s cabotegravir drug. The injection, called Apretude (cabotegravir extended-release injectable suspension),…


China’s HIV Cases Reach 1 Million With Prevalence Among Youth: Study

HIV and AIDS remain a major public health problem and cause of death in China, with more than a million people reportedly having HIV at the end of 2020, according to a recent report. In the past decade, China’s HIV infection rates have increased significantly for men of all age groups, with a growing prevalence…


HIV Self-Tests Soon Available in Australian Pharmacies

HIV self-test kits will be soon available in Australian pharmacies from mid-December as a critically important additional tool to help people know their HIV status. The devices will cost $25 each and will first be available at Serafim’s pharmacy at Taylor Square in Sydney and the 777 pharmacy network in Western Australia, with other pharmacies…